ZA9410092B - Methods of inhibiting hirsutism and alopecia in women - Google Patents
Methods of inhibiting hirsutism and alopecia in womenInfo
- Publication number
- ZA9410092B ZA9410092B ZA9410092A ZA9410092A ZA9410092B ZA 9410092 B ZA9410092 B ZA 9410092B ZA 9410092 A ZA9410092 A ZA 9410092A ZA 9410092 A ZA9410092 A ZA 9410092A ZA 9410092 B ZA9410092 B ZA 9410092B
- Authority
- ZA
- South Africa
- Prior art keywords
- alopecia
- women
- methods
- hirsutism
- inhibiting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/171,089 US5574048A (en) | 1993-12-21 | 1993-12-21 | Methods of inhibiting hirsutism and alopecia in women |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA9410092B true ZA9410092B (en) | 1996-06-19 |
Family
ID=22622479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA9410092A ZA9410092B (en) | 1993-12-21 | 1994-12-19 | Methods of inhibiting hirsutism and alopecia in women |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US5574048A (ja) |
| EP (1) | EP0659414B1 (ja) |
| JP (1) | JPH07215864A (ja) |
| KR (1) | KR950016728A (ja) |
| CN (1) | CN1107703A (ja) |
| AT (1) | ATE203406T1 (ja) |
| AU (1) | AU690162B2 (ja) |
| CA (1) | CA2138498A1 (ja) |
| CZ (1) | CZ321394A3 (ja) |
| DE (1) | DE69427807T2 (ja) |
| DK (1) | DK0659414T3 (ja) |
| ES (1) | ES2157961T3 (ja) |
| GR (1) | GR3036977T3 (ja) |
| HU (1) | HUT71479A (ja) |
| IL (1) | IL112040A0 (ja) |
| NO (1) | NO944920L (ja) |
| NZ (1) | NZ270171A (ja) |
| PH (1) | PH31440A (ja) |
| PT (1) | PT659414E (ja) |
| RU (1) | RU94044457A (ja) |
| SI (1) | SI0659414T1 (ja) |
| ZA (1) | ZA9410092B (ja) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5965551A (en) * | 1996-02-21 | 1999-10-12 | North Carolina State University | Method of treating alopecia |
| IL120266A (en) | 1996-02-28 | 2005-05-17 | Pfizer | Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions |
| TW442286B (en) * | 1996-02-28 | 2001-06-23 | Pfizer | New therapeutic uses of estrogen agonists |
| US6630453B1 (en) | 1999-05-04 | 2003-10-07 | Strakan Limited | Androgen derivatives and uses thereof |
| US20060263452A1 (en) * | 2005-05-17 | 2006-11-23 | Alwyn Dowell | Topical composition containing essential oils |
| EP2459187B1 (en) | 2009-07-29 | 2021-01-06 | Olsen, Elise | Compositions and methods for inhibiting hair growth |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
| US4380635A (en) * | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
| US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
| US4859585A (en) * | 1986-04-17 | 1989-08-22 | Trustees Of Tufts College | In-vitro methods for identifying compositions which are agonists and antagonists of estrogens |
| US5075321A (en) * | 1987-03-24 | 1991-12-24 | University Of Pennsylvania | Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes |
| US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
| JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
-
1993
- 1993-12-19 CZ CZ943213A patent/CZ321394A3/cs unknown
- 1993-12-21 US US08/171,089 patent/US5574048A/en not_active Expired - Fee Related
-
1994
- 1994-12-16 RU RU94044457/14A patent/RU94044457A/ru unknown
- 1994-12-19 CN CN94119731A patent/CN1107703A/zh active Pending
- 1994-12-19 ES ES94309471T patent/ES2157961T3/es not_active Expired - Lifetime
- 1994-12-19 NZ NZ270171A patent/NZ270171A/en unknown
- 1994-12-19 JP JP6314549A patent/JPH07215864A/ja active Pending
- 1994-12-19 SI SI9430389T patent/SI0659414T1/xx unknown
- 1994-12-19 HU HU9403665A patent/HUT71479A/hu unknown
- 1994-12-19 ZA ZA9410092A patent/ZA9410092B/xx unknown
- 1994-12-19 PH PH49587A patent/PH31440A/en unknown
- 1994-12-19 EP EP94309471A patent/EP0659414B1/en not_active Expired - Lifetime
- 1994-12-19 CA CA002138498A patent/CA2138498A1/en not_active Abandoned
- 1994-12-19 AT AT94309471T patent/ATE203406T1/de not_active IP Right Cessation
- 1994-12-19 AU AU81550/94A patent/AU690162B2/en not_active Ceased
- 1994-12-19 NO NO944920A patent/NO944920L/no unknown
- 1994-12-19 DK DK94309471T patent/DK0659414T3/da active
- 1994-12-19 PT PT94309471T patent/PT659414E/pt unknown
- 1994-12-19 KR KR1019940034919A patent/KR950016728A/ko not_active Application Discontinuation
- 1994-12-19 DE DE69427807T patent/DE69427807T2/de not_active Expired - Fee Related
- 1994-12-19 IL IL11204094A patent/IL112040A0/xx unknown
-
1995
- 1995-03-15 US US08/404,858 patent/US5686468A/en not_active Expired - Fee Related
-
2001
- 2001-10-22 GR GR20010401847T patent/GR3036977T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PH31440A (en) | 1998-11-03 |
| US5686468A (en) | 1997-11-11 |
| ES2157961T3 (es) | 2001-09-01 |
| KR950016728A (ko) | 1995-07-20 |
| RU94044457A (ru) | 1996-10-10 |
| HUT71479A (en) | 1995-11-28 |
| NO944920L (no) | 1995-06-22 |
| CN1107703A (zh) | 1995-09-06 |
| EP0659414B1 (en) | 2001-07-25 |
| DK0659414T3 (da) | 2001-09-24 |
| DE69427807T2 (de) | 2001-12-06 |
| GR3036977T3 (en) | 2002-01-31 |
| HU9403665D0 (en) | 1995-02-28 |
| IL112040A0 (en) | 1995-03-15 |
| CZ321394A3 (en) | 1995-08-16 |
| ATE203406T1 (de) | 2001-08-15 |
| AU8155094A (en) | 1995-06-29 |
| AU690162B2 (en) | 1998-04-23 |
| CA2138498A1 (en) | 1995-06-22 |
| JPH07215864A (ja) | 1995-08-15 |
| NO944920D0 (no) | 1994-12-19 |
| DE69427807D1 (de) | 2001-08-30 |
| PT659414E (pt) | 2001-11-30 |
| SI0659414T1 (en) | 2001-12-31 |
| US5574048A (en) | 1996-11-12 |
| EP0659414A2 (en) | 1995-06-28 |
| EP0659414A3 (en) | 1995-09-06 |
| NZ270171A (en) | 1996-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL112048A0 (en) | Methods of inhibiting thrombin | |
| ZA948029B (en) | Methods for inhibiting endometriosis | |
| ZA9410086B (en) | Methods of inhibiting seborrhea and acne | |
| IL111285A0 (en) | Methods of inhibiting uterine fibrosis | |
| PH31260A (en) | Methods for inhibiting angiogenesis. | |
| ZA9410094B (en) | Method of increasing libido in post-menopausal women | |
| AU8156294A (en) | Methods of inhibiting CNS problems in post-menopausal women | |
| HU9403665D0 (en) | Methods of inhibiting hirsutism and alopecia in women |